BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15115390)

  • 21. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P2 alpha-amino acid by a alpha-hydroxy acid.
    Wang Y; Guan L; Jia S; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1379-83. PubMed ID: 15713391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.
    Sun H; Nikolovska-Coleska Z; Yang CY; Xu L; Tomita Y; Krajewski K; Roller PP; Wang S
    J Med Chem; 2004 Aug; 47(17):4147-50. PubMed ID: 15293984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score.
    Yoshimori A; Takasawa R; Tanuma S
    BMC Pharmacol; 2004 May; 4():7. PubMed ID: 15154972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.
    McStay GP; Salvesen GS; Green DR
    Cell Death Differ; 2008 Feb; 15(2):322-31. PubMed ID: 17975551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a novel class of reversible non-peptide caspase inhibitors via a structure-based approach.
    Fattorusso R; Jung D; Crowell KJ; Forino M; Pellecchia M
    J Med Chem; 2005 Mar; 48(5):1649-56. PubMed ID: 15743206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acylaminoacyl peptidase from Aeropyrum pernix K1 thought to be an exopeptidase displays endopeptidase activity.
    Kiss AL; Hornung B; Rádi K; Gengeliczki Z; Sztáray B; Juhász T; Szeltner Z; Harmat V; Polgár L
    J Mol Biol; 2007 Apr; 368(2):509-20. PubMed ID: 17350041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease.
    Ontoria JM; Di Marco S; Conte I; Di Francesco ME; Gardelli C; Koch U; Matassa VG; Poma M; Steinkühler C; Volpari C; Harper S
    J Med Chem; 2004 Dec; 47(26):6443-6. PubMed ID: 15588076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.
    Mellon C; Aspiotis R; Black CW; Bayly CI; Grimm EL; Giroux A; Han Y; Isabel E; McKay DJ; Nicholson DW; Rasper DM; Roy S; Tam J; Thornberry NA; Vaillancourt JP; Xanthoudakis S; Zamboni R
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3886-90. PubMed ID: 16023344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and biophysical characterization of inhibitor binding to caspase-3 reveals induced asymmetry.
    Aulabaugh A; Kapoor B; Huang X; Dollings P; Hum WT; Banker A; Wood A; Ellestad G
    Biochemistry; 2007 Aug; 46(33):9462-71. PubMed ID: 17649976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-guided discovery of cyclin-dependent kinase inhibitors.
    Fischmann TO; Hruza A; Duca JS; Ramanathan L; Mayhood T; Windsor WT; Le HV; Guzi TJ; Dwyer MP; Paruch K; Doll RJ; Lees E; Parry D; Seghezzi W; Madison V
    Biopolymers; 2008 May; 89(5):372-9. PubMed ID: 17937404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.
    Han Y; Giroux A; Colucci J; Bayly CI; Mckay DJ; Roy S; Xanthoudakis S; Vaillancourt J; Rasper DM; Tam J; Tawa P; Nicholson DW; Zamboni RJ
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1173-80. PubMed ID: 15686936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2005 Feb; 327(2):589-96. PubMed ID: 15629154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
    Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
    Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and properties of the first all-aza analogue of a biologically active peptide.
    Gante J; Krug M; Lauterbach G; Weitzel R; Hiller W
    J Pept Sci; 1995; 1(3):201-6. PubMed ID: 9222997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid.
    Wang Y; Huang JC; Zhou ZL; Yang W; Guastella J; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1269-72. PubMed ID: 14980679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human caspase-3 inhibition by Z-tLeu-Asp-H: tLeu(P2) counterbalances Asp(P4) and Glu(P3) specific inhibitor truncation.
    Colantonio P; Leboffe L; Bolli A; Marino M; Ascenzi P; Luisi G
    Biochem Biophys Res Commun; 2008 Dec; 377(3):757-62. PubMed ID: 18854175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tethering identifies fragment that yields potent inhibitors of human caspase-1.
    Fahr BT; O'Brien T; Pham P; Waal ND; Baskaran S; Raimundo BC; Lam JW; Sopko MM; Purkey HE; Romanowski MJ
    Bioorg Med Chem Lett; 2006 Feb; 16(3):559-62. PubMed ID: 16274992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.